Harmony Biosciences Announces Positive Results From the Pivotal Bioequivalence Study for Pitolisant Gastro-Resistant Formulation
PLYMOUTH MEETING, Pa.–(BUSINESS WIRE)–Nov. 24, 2025– Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced positive resu...





